GSK
GSK | NYSE
$49.51
+$0.83 (+1.71%)
At close: Oct 30, 2026, 4:00 PM ET
$49.26
-$0.25 (-0.50%)
Pre-market:
Nov 2, 2026, 7:56 AM ET
Market Data
Market Cap $99.24B
Enterprise Value $95.7B
Beta 0.28
Average Volume 4.18M
Shares Outstanding (Diluted) 2.04B
Shares Change YoY -0.71%
Institutional Ownership 17.30%
Exchange NYSE
ISIN US37733W2044
Price Performance
Price Change 1M 2.8%
Price Change 3M -4.2%
Price Change 6M -4.1%
Price Change YTD 1.0%
Price Change 1Y 5.7%
Price Change 3Y 38.7%
Price Change 5Y 17.0%
1M CAGR (ann.) -1.4%
1Y CAGR (ann.) 11.6%
5Y CAGR (ann.) 8.8%
All-Time CAGR 4.5%
Valuation
PE Ratio 17.10
Forward PE 9.53
PEG Ratio -0.83
Forward PEG 2.90
PS Ratio 2.21
Forward PS 2.10
PB Ratio 3.96
P/FCF Ratio 10.89
P/Adj. FCF Ratio 10.89
P/OCF Ratio 8.65
EV/Sales 2.86
EV/EBIT 14.68
EV/EBITDA 10.97
EV/FCF 14.09
Earnings Yield 5.9%
FCF Yield 9.2%
Adj. FCF Yield 9.2%
Financial Health
Net Debt £20.88B
Total Debt £23.86B
Cash & Short-Term Investments £2.98B
Total Assets £72.18B
Current Ratio 0.86
Quick Ratio 0.56
Debt / Equity Ratio 1.26
Debt / EBITDA 2.73
Debt / FCF 3.51
OCF / Debt 0.36
Interest Coverage 10.56
Altman Z-Score 1.80
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 73.5%
Operating Profit Margin 20.4%
EBITDA Margin 31.7%
Net Profit Margin 13.0%
FCF Margin 20.3%
Adj. FCF Margin 20.3%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets 6.1%
Return on Equity 24.6%
Return on Invested Capital 13.5%
Return on Capital Employed 15.7%
Return on Tangible Assets 11.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 4.1%
Revenue CAGR 5Y 3.2%
Revenue CAGR 10Y 2.3%
EPS CAGR 3Y -10.2%
EPS CAGR 5Y 0.0%
EPS CAGR 10Y 29.7%
FCF CAGR 3Y 27.9%
FCF CAGR 5Y -3.8%
FCF CAGR 10Y 9.5%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 2
EPS Growth Next 3Y 25.4%
Revenue Growth Next 3Y 4.5%
Earnings Date Feb 3, 2027
EPS Estimate (next Q) $1.02
EPS Growth Est (next Q) 11.8%
Revenue Est (next Q) $15.85B
Revenue Growth Est (next Q) 0.1%
Fair Value Estimates
Graham Number $27.98
Graham Upside -43.5%
Lynch Fair Value $14.48
Lynch Upside -70.8%
Price Target $57.95
Price Target Upside 17.0%
Cash Flow
Operating Cash Flow £8.5B
Free Cash Flow £6.79B
Adj. Free Cash Flow £6.79B
FCF Per Share $3.41
OCF Per Share $4.27
OCF/S Ratio 25.5%
Income Statement
Revenue £33.47B
Gross Profit £24.42B
Operating Income £6.83B
EBITDA £8.73B
Net Income £4.34B
EPS (Diluted) $2.16
Revenue / Employee $500.79K
Profit / Employee $64.91K
Employees 66,841
Dividends
Annual Dividend $1.82
Dividend Yield 3.68%
Payout Ratio 84.1%
FCF Payout Ratio 39.4%
Adj. FCF Payout Ratio 39.4%
Dividend Growth (YoY) 9.8%
Pay Frequency Quarterly
Ex-Dividend Date Nov 13, 2026
Add to Watchlist
Select watchlists to add or remove GSK